Skip to main content

Hormone Replacement Therapy Market to Exhibit a CAGR of 6.0% and Reach USD 20.76 Billion by 2026; Rising Prevalence of Thyroid Disorders to Spur Demand, states Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Nov. 02, 2020 (GLOBE NEWSWIRE) — The global hormone replacement therapy market size is predicted to reach USD 20.76 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing cases of hormone-related disorders in both men and women of different age groups will spur demand for hormone replacement therapy, which in turn, will boost the hormone replacement therapy market growth during the forecast period.  In addition, the increasing prevalence of disorders such as growth deficiency, thyroid disorders, and others will create new sales opportunities for the market in the forthcoming years. The market in North America generated a revenue of USD 6.89 billion in 2018 and is expected to grow rapidly during the forecast period. The growth in the region is attributed to the rising prevalence of menopause disorders and growing incidence of hormone deficiency disorders. Key Prominent Players Covered in the Hormone Replacement Therapy Market Research Report Are Novo Nordisk A/S, Pfizer Inc., AbbVie Inc., Merck KGaA, Endo Pharmaceuticals Solutions Inc., Allergan, Eli Lilly and Company, Mithra Pharmaceuticals and other key market players.
KEY INDUSTRY DEVELOPMENTS:January 2020 – CurieMD, telehealth platform launched menopause hormone replacement therapy management through telehealth service which offers women remote consultation, mail-order prescription, and consumer video consultation with midlife health practitioners for the consultation.October 2018 – TherapeuticsMD, Inc., the company mainly focuses on women’s health, announced FDA approval of bijuva consisting of estradiol and progesterone combination capsules for the treatment of vasomotor symptoms during moderate to severe menopause disorders.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hormone-replacement-therapy-hrt-market-102543
The market size stood at USD 13.00 billion in 2018. The global hormone replacement therapy market report focuses and elaborates the definition, types, applications and major players in detail. Deep analysis about market status, competition pattern, enterprise, advantages and disadvantages of enterprise products, industry development trends, regional industrial layout characteristics and macroeconomic policies, industrial policy has also been studied and provided within the synopsis.From raw materials to downstream buyers of this industry has been analysed scientifically, the feature of product circulation and sales channel is presented as well. This report is aimed at helping companies, investors and potential shareholders along with venture capitalists establish a bird’s eye view prospect of industrial development and characteristics of the market. The report also benefits its readers by providing the unrivalled data in well-organized manner.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/hormone-replacement-therapy-hrt-market-102543

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.